WFDC2 and neoplasm: No significant differences were evident in BMI, dysmenorrhea history, endometriosis history, operation history, complications, ascites, tumor size, type of surgery and relevant serum tumor markers (CA125, HE4, CA19.9) between the two groups (all P > 0.05), consistent with earlier results.